About
Insilico Medicine is a Hong Kong-based biotechnology company applying generative AI to accelerate the discovery and development of novel therapeutics. Their core technology is Pharma.AI, an end-to-end platform utilizing deep learning for target identification, molecule generation, and clinical trial prediction. Insilico Medicine focuses on discovering drugs for age-related diseases and extending healthy longevity, aiming to reduce the time and cost associated with traditional pharmaceutical R&D.
Focus Areas
Technology Focus
generative ai healthcare drug discovery
Key People
A
Alex Zhavoronkov Quick Stats
Total Raised $410M
Founded 2014
Status private
Type startup
Connect
Explore More
Similar Companies
Genesis Therapeutics
Burlingame, United States
93%
4 shared categories
3 shared AI types
Drug DiscoveryHealthcare AI +2
Tempus AI
Chicago, United States
89%
4 shared categories
3 shared AI types
Healthcare AIGenerative AI +2
Exscientia
Oxford, United Kingdom
89%
4 shared categories
3 shared AI types
Drug DiscoveryHealthcare AI +2
Isomorphic Labs
London, United Kingdom
89%
4 shared categories
3 shared AI types
Drug DiscoveryGenerative AI +2